Pathogenesis of human immunodeficiency virus infection and prospects for control

Yale J Biol Med. 1987 Nov-Dec;60(6):589-600.

Abstract

In just six years after the initial description of the acquired immunodeficiency syndrome, much has been learned about the etiologic agent, the human immunodeficiency virus. The pathogenic mechanisms utilized by this virus to infect selectively and persistently T4+ lymphocytes and monocyte/macrophages, leading to immunodeficiency and neurologic dysfunction, are slowly becoming clear. Better understanding of the pathogenesis of human immunodeficiency virus infection is essential for the rational design of therapeutic and preventive strategies to combat this deadly virus.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Acquired Immunodeficiency Syndrome / etiology*
  • Acquired Immunodeficiency Syndrome / microbiology
  • Acquired Immunodeficiency Syndrome / prevention & control
  • Antiviral Agents / therapeutic use
  • HIV / immunology
  • HIV / physiology*
  • Humans
  • Macrophages / microbiology
  • Monocytes / microbiology
  • T-Lymphocytes / microbiology
  • Viral Vaccines*
  • Virus Replication

Substances

  • Antiviral Agents
  • Viral Vaccines